Argenx Se ADR (ARGX)
624.54 +3.57 (+0.57%) 10:37 ET [NASDAQ]
623.40 x 100 624.17 x 100
Realtime by (Cboe BZX)
623.40 x 100 624.17 x 100
Realtime 623.80 +2.83 (+0.46%) 09:04 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ARGX | REGN | ALNY | ||
| Company | Argenx Se ADR | Regeneron Pharmaceuticals | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 624.95 | 561.75 | 256.14 | ||
| High | 626.06 | 566.00 | 258.87 | ||
| Low | 623.16 | 542.44 | 253.83 | ||
| Last | 624.54 | 569.43 | 256.89 | ||
| Change | +3.57 | -41.43 | +2.04 | ||
| % Change | +0.57% | -6.78% | +0.80% | ||
| Volume | 34,805 | 802,951 | 90,478 | ||
| 20-Day Average Volume | 430,531 | 1,095,123 | 1,033,332 | ||
| Previous Close | 620.97 | 610.86 | 254.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 586.59 | 579.08 | 241.95 | ||
| 20-Day Raw Stochastic | 97.86% | 28.26% | 76.12% | ||
| 20-Day Relative Strength | 56.19% | 39.33% | 53.87% | ||
| Weighted Alpha | +50.68 | -47.36 | +27.59 | ||
| Today's Opinion | 40% Buy | 100% Sell | 56% Sell | ||
| Previous Opinion | 56% Buy | 88% Sell | 56% Sell | ||
| Last Month's Opinion | 8% Sell | 100% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.97% since 04/22/25 | -4.60% since 04/22/25 | +8.73% since 04/22/25 | ||
| Low | 593.31 on 04/23/25 | 542.85 on 04/29/25 | 238.62 on 04/24/25 | ||
| High | 625.97 on 04/29/25 | 614.83 on 04/28/25 | 258.87 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | +5.86% since 03/28/25 | -12.36% since 03/28/25 | -4.11% since 03/28/25 | ||
| Low | 519.70 on 04/09/25 | 525.99 on 04/09/25 | 205.87 on 04/09/25 | ||
| High | 625.97 on 04/29/25 | 641.24 on 04/01/25 | 273.61 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | -4.74% since 01/29/25 | -18.73% since 01/29/25 | -6.04% since 01/29/25 | ||
| Low | 519.70 on 04/09/25 | 525.99 on 04/09/25 | 205.87 on 04/09/25 | ||
| High | 672.40 on 02/05/25 | 748.29 on 03/10/25 | 300.90 on 03/24/25 | ||
| 6-Month | |||||
| %Chg | +12.81% since 10/29/24 | -39.77% since 10/29/24 | -9.58% since 10/29/24 | ||
| Low | 519.70 on 04/09/25 | 525.99 on 04/09/25 | 205.87 on 04/09/25 | ||
| High | 678.21 on 01/14/25 | 935.86 on 10/30/24 | 300.90 on 03/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 37,916,428 | 66,782,260 | 33,152,164 | ||
| Shares Outstanding, K | 61,060 | 109,325 | 130,085 | ||
| Annual Sales | 2,252,040,000 | 14,202,000,000 | 2,248,240,000 | ||
| Annual Net Income | 833,040,000 | 4,412,600,000 | -278,160,000 | ||
| Last Quarter Sales | 761,220,000 | 3,789,200,000 | 593,170,000 | ||
| Last Quarter Net Income | 774,160,000 | 917,700,000 | -83,760,000 | ||
| 60-Month Beta | 0.60 | 0.44 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.58 on 02/27/25 | 12.07 on 02/04/25 | 0.06 on 02/13/25 | ||
| Latest Earnings Date | 05/08/25 | 04/29/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | 0.880 on 02/20/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 258.30 | 15.18 | 0.00 | ||